Additional file 1 of Transesophageal echocardiography for cardiovascular risk estimation in patients with sepsis and new-onset atrial fibrillation: a multicenter prospective pilot study

Additional file 1: Table S1. Definition of CHA2DS2-VASc and HAS-BLED risk scores, arterial thromboembolic events, and bleeding events. Table S2. Stop Stroke Study Trial of Org 10172 in Acute Stroke Treatment (SSS-TOAST) Classification Criteria to Determine Causative Subtypes of Acute Ischemic Stroke. Figure S1. The decision algorithm to assign a mechanism using the Stop Stroke Study Trial of Org 10172 in Acute Stroke Treatment (SSS-TOAST) Classification Criteria. Table S3. Initial transthoracic and transesophageal echocardiographic variables according to 28-day cardiovascular events. Table S4. New onset atrial fibrillation and sepsis management during 28-day follow-up in intensive care unit. Table S5. Description of 28-day ISTH major bleeding events. Table S6. Baseline clinical characteristics at intensive care unit admission, initial severity and new-onset atrial fibrillation management according to 28-day cardiovascular events. Table S7. Multivariate analyses of factors associated with cardiovascular events including baseline clinical characteristics (SAPSII score, CHADS2Vasc2 and HAS-BLED) and antithrombotic management (antiplatelet therapy and therapeutic anticoagulation on the day of NOAF onset).